Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Myasthenia Gravis Treatments Are Associated with Negative Patient Sentiment in Digital Conversation Data

Author:Pesa, Jacqueline   Chaudhry, Zia   Brethenoux, Caroline   Furey, Patrick   Gil Valletta, Lili   Gonzalez Quijano, Laura   Lorenzo, Alex   

Session Name:P7: Neuromuscular Disease: Neuromuscular Junction Disorders 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.013  

Author Institution:Janssen Scientific Affairs, LLC, Superior, CO  Janssen Scientific Affairs, LLC, Titusville, NJ  CulturIntel, New York, NY  CulturIntel, New York, NJ  

Small Molecule Inhibitors for Precise Inhibition of Alpha-Synuclein Oligomer Generation in Parkinson’s Disease

Author:Thomson, John   Cridland, Andrew   Ball, Sarah   Staats, Roxine   Pandey, Samata   Castellana Cruz, Marta   Pisani, Katarina   Meisl, Georg   Kitchen-Smith, Isaac   Yang, Xiaoting   Mannini, Benedetta   Pollack, Scott   Rajah, Luke   Brewerton, Suzanne   Habchi, Johnny   Plowright, Alleyn   

Session Name:S32: Movement Disorders: Trials  

Topic:Movement Disorders  

Program Number:S32.002  

Author Institution:Wren Therapeutics, Boston, MA  Wren Therapeutics, Cambridge, United Kingdom  

a-Synuclein membrane-binding in the central and enteric nervous system in Parkinson’s disease

Author:Gao, Virginia   Briano, Juan   Komer, Lauren   Crawford, Carl   Henchcliffe, Claire   Lee, Andrea   Burré, Jacqueline   

Session Name:P3: Movement Disorders: Biomarkers and Genetics of Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P3.002  

Author Institution:Appel Institute for Alzheimer’s Disease Research, Brain and Mind Research Institute, Weill Cornell Medical College, Brooklyn, NY  Weill Cornell Medical College, New York, NY  University of California, Irvine, Orange, CA  University of Kansas Medical Center, NEW YORK, NY  

Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage

Author:Furr-Stimming, Erin   Sung, Victor   Reshef, Shoshana   Willock, Rosa   Ribalov, Rinat   Brighton, Sarah   Leo, Sam   

Session Name:P1: Movement Disorders: Huntington's Disease and Chorea 1  

Topic:Movement Disorders  

Program Number:P1.010  

Author Institution:University of Texas Health Science Center-Houston, Houston, TX  University of Alabama At Birmingham, Birmingham, AL  Teva Branded Pharmaceutical Products R&D, Inc., Parsippany, NJ  HCD Economics, Daresbury, United Kingdom  Teva Pharmaceuticals Ltd., Tel Aviv, Israel  HCD Economics, Macclesfield, United Kingdom  

Baseline Characteristics and Treatment Patterns of a Global Huntington Disease Population Stratified by Chorea Severity

Author:Sung, Victor   Furr-Stimming, Erin   Reshef, Shoshana   Willock, Rosa   Ribalov, Rinat   Brighton, Sarah   Leo, Sam   

Session Name:P2: Movement Disorders: Huntington's Disease and Chorea 2  

Topic:Movement Disorders  

Program Number:P2.011  

Author Institution:University of Alabama At Birmingham, Birmingham, AL  University of Texas Health Science Center-Houston, Houston, TX  Teva Branded Pharmaceutical Products R&D, Inc., Parsippany, NJ  HCD Economics, Daresbury, United Kingdom  Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel  HCD Economics, Macclesfield, United Kingdom